Inhibitory effects of polyphenols isolated from Rhus verniciflua on Aldo-keto reductase family 1 B10

BMB Reports

Volumn 43, Issue 4, 2010, Pages 268-272

  Song, Dae Geun ^a   Lee, Joo Young ^a   Lee, Eun Ha ^a   Jung, Sang Hoon ^a   Nho, Chu Won ^a   Cha, Kwang Hyun ^a   Koo, Song Yi ^a   Pan, Cheol Ho ^a  

^a Korea Institute of Science and Technology   (South Korea)

Author keywords

AKR1B10; Aldo keto reductase; Aldose reductase like; Anticancer; Butein; Polyphenol; Rhus verniciflua

Indexed keywords

TOXICODENDRON VERNICIFLUUM;

EID: 77953528179     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2010.43.4.268     Document Type: Article

References (27)

1. Cao, D., Fan, S. T. and Chung, S. S. (1998) Identification and characterization of a novel human aldose reductase-like gene. J. Biol. Chem. 273, 11429-11435.
2. Crosas, B., Hyndman, D. J., Gallego, O., Martras, S., Pares, X., Flynn, T. G. and Farres, J. (2003) Human aldose reductase and human small intestine aldose reductase are efficient retinal reductases: consequences for retinoid metabolism. Biochem J. 373, 973-979.
3. Endo, S., Matsunaga, T., Mamiya, H., Ohta, C., Soda, M., Kitade, Y., Tajima, K., Zhao, H. T., El-Kabbani, O. and Hara, A. (2009) Kinetic studies of AKR1B10, human aldose reductase-like protein: endogenous substrates and inhibition by steroids. Arch. Biochem. Biophys. 487, 1-9.
4. Scuric, Z., Stain, S. C., Anderson, W. F. and Hwang, J. J. (1998) New member of aldose reductase family proteins overexpressed in human hepatocellular carcinoma. Hepatology. 27, 943-950.
5. Fukumoto, S., Yamauchi, N., Moriguchi, H., Hippo, Y., Watanabe, A., Shibahara, J., Taniguchi, H., Ishikawa, S., Ito, H., Yamamoto, S., Iwanari, H., Hironaka, M., Ishikawa, Y., Niki, T., Sohara, Y., Kodama, T., Nishimura, M., Fukayama, M., Dosaka-Akita, H. and Aburatani, H. (2005) Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers' non small cell lung carcinomas. Clin. Cancer. Res. 11, 1776-1785.
6. Yoshitake, H., Takahashi, M., Ishikawa, H., Nojima, M., Iwanari, H., Watanabe, A., Aburatani, H., Yoshida, K., Ishi, K., Takamori, K., Ogawa, H., Hamakubo, T., Kodama, T. and Araki, Y. (2007) Aldo-keto reductase family 1, member B10 in uterine carcinomas: a potential risk factor of recurrence after surgical therapy in cervical cancer. Int. J. Gynecol. Cancer. 17, 1300-1306.
7. Penning, T. M. (2005) AKR1B10: a new diagnostic marker of non-small cell lung carcinoma in smokers. Clin. Cancer. Res. 11, 1687-1690.
8. Yan, R., Zu, X., Ma, J., Liu, Z., Adeyanju, M. and Cao, D. (2007) Aldo-keto reductase family 1 B10 gene silencing results in growth inhibition of colorectal cancer cells: implication for cancer intervention. Int. J. Cancer. 121, 2301-2306.
9. Ma, J., Yan, R., Zu, X., Cheng, J. M., Rao, K., Liao, D. F. and Cao, D. (2008) Aldo-keto reductase family 1 B10 affects fatty acid synthesis by regulating the stability of acetyl-CoA carboxylase-alpha in breast cancer cells. J. Biol. Chem. 283, 3418-3423.
10. Wang, C., Yan, R., Luo, D., Watabe, K., Liao, D. F. and Cao, D. (2009) Aldo-keto reductase family 1 member B10 promotes cell survival by regulating lipid synthesis and eliminating carbonyls. J. Biol. Chem. 284, 26742-26748.
11. Frank, R. N., Keirn, R. J., Kennedy, A. and Frank, K. W. (1983) Galactose-induced retinal capillary basement membrane thickening: prevention by Sorbinil. Invest. Ophthalmol. Vis. Sci. 24, 1519-1524.
12. Young, R. J., Ewing, D. J. and Clarke, B. F. (1983) A controlled trial of sorbinil, an aldose reductase inhibitor, in chronic painful diabetic neuropathy. Diabetes. 32, 938-942.
13. Dunlop, M. (2000) Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney Int. Suppl. 77, S3-12.
14. Robison, W. G., Jr., Nagata, M., Laver, N., Hohman, T. C. and Kinoshita, J. H. (1989) Diabetic-like retinopathy in rats prevented with an aldose reductase inhibitor. Invest. Ophthalmol. Vis. Sci. 30, 2285-2292.
15. Gallego, O., Ruiz, F. X., Ardevol, A., Dominguez, M., Alvarez, R., de Lera, A. R., Rovira, C., Farres, J., Fita, I. and Pares, X. (2007) Structural basis for the high all trans retinaldehyde reductase activity of the tumor marker AKR1BProc. Natl. Acad. Sci. U.S.A. 104, 20764-20769.
16. Spite, M., Baba, S. P., Ahmed, Y., Barski, O. A., Nijhawan, K., Petrash, J. M., Bhatnagar, A. and Srivastava, S. (2007) Substrate specificity and catalytic efficiency of aldo-keto reductases with phospholipid aldehydes. Biochem. J. 405, 95-105.
17. Lee, E. H., Song, D. G., Lee, J. Y., Pan, C. H., Um, B. H. and Jung, S. H. (2008) Inhibitory effect of the compounds isolated from Rhus verniciflua on aldose reductase and advanced glycation endproducts. Biol. Pharm. Bull. 31, 1626-1630.
18. Jung, C. H., Kim, J. H., Hong, M. H., Seog, H. M., Oh, S. H., Lee, P. J., Kim, G. J., Kim, H. M., Um, J. Y. and Ko, S. G. (2007) Phenolic-rich fraction from Rhus verniciflua Stokes (RVS) suppress inflammatory response via NF appaB and JNK pathway in lipopolysaccharide-induced RAW 264.7 macrophages. J. Ethnopharmacol. 110, 490-497.
19. Samoszuk, M., Tan, J. and Chorn, G. (2005) The chalcone butein from Rhus verniciflua Stokes inhibits clonogenic growth of human breast cancer cells co-cultured with fibroblasts. BMC. Complement. Altern. Med. 5, 5.
20. Pan, C. H., Lee, J. Y., Song. D. G., Kim, J. H., Ahn, S. Y., Bae, D. S., Kim, Y. H. and Lee, J. K. (2009) Antioxidant and Aldo-keto reductase family 1 B10 inhibition activities of Korean local plant extracts. J. Appl. Biol. Chem. 52, 216-220.
21. Matsunaga, T., Endo, S., Soda, M., Zhao, H. T., El- abbani, O., Tajima, K. and Hara, A. (2009) Potent and selective inhibition of the tumor marker AKR1B10 by bisdemethoxycurcumin: probing the active site of the enzyme with molecular modeling and site directed mutagenesis. Biochem. Biophys. Res. Commun. 389, 128-132.
22. Lee, J. Y., Song, D. G., Lee, E. H., Jung, S. H., Nho, C. W., Cha, K. H. and Pan, C. H. (2009) Inhibitory effects of 3,5-O-dicaffeoyl-epiquinic acid from Gymnaster koraiensis on AKR1B10. J. Korean. Soc. Appl. Biol. Chem. 52, 731-734.
23. Zhang, L., Chen, W. and Li, X. (2008) A novel anticancer effect of butein: inhibition of invasion through the ERK1/2 and NF-kappa B signaling pathways in bladder cancer cells. FEBS. Lett. 582, 1821-1828.
24. Moon, D. O., Kim, M. O., Choi, Y. H., Hyun, J. W., Chang, W. Y. and Kim, G. Y. (2010) Butein induces G(2)/phase arrest and apoptosis in human hepatoma cancer cells through ROS generation. Cancer Lett. 288, 204-213
25. de la Fuente, J. A. and Manzanaro, S. (2003) Aldose reductase inhibitors from natural sources. Nat. Prod. Rep. 20, 243-251.
26. Lee, J. Y., Song, D. G,. Jung, S. H., Kim, J. H., Ahn, S. Y., Nho, C. W. and Pan, C. H. (2009) Inhibitory effects of Korean local plant extracts on AKR1B10 Korean J. Pharmacognosy. 40, 238-243.
27. Sato, S. and Kador, P. F. (1990) Inhibition of aldehyde reductase by aldose reductase inhibitors. Biochem. Pharmacol. 40, 1033-1042.